J9320 Streptozocin injection
Also known as: streptozocin, Zanosar
Injection of streptozocin, a methylnitrosourea alkylating agent. Used for neuroendocrine tumors and pancreatic islet cell carcinoma.
In Plain Language
pancreatic cancer injection; neuroendocrine tumor treatment
Clinical Context
Used for metastatic pancreatic neuroendocrine tumors (islet cell carcinoma). Often combined with 5-fluorouracil or doxorubicin.
RVU Information
CPT J9320 does not have a physician work RVU assigned by CMS. This is typical for supply, drug, and equipment codes — reimbursement is based on Average Sales Price (ASP), fee schedules, or payer contracts rather than the RVU system.
Billing & Documentation
J-codes represent drugs administered by a healthcare provider (not self-administered). Documentation must include the drug name, dosage, route of administration, and medical necessity. Most payers require the National Drug Code (NDC) on the claim. Bill the appropriate administration code (96365-96379) in addition to the drug code.
Specialties
Frequently Asked Questions
What is CPT code J9320?
CPT J9320 (Streptozocin injection) is a J Codes (Drugs) code. Injection of streptozocin, a methylnitrosourea alkylating agent. Used for neuroendocrine tumors and pancreatic islet cell carcinoma.
How is J9320 administered?
CPT J9320 is administered by a healthcare provider, typically via injection or infusion. Used for metastatic pancreatic neuroendocrine tumors (islet cell carcinoma). Often combined with 5-fluorouracil or doxorubicin. It is used by Oncology, Surgery, Gastroenterology.
When is CPT J9320 used?
Used for metastatic pancreatic neuroendocrine tumors (islet cell carcinoma). Often combined with 5-fluorouracil or doxorubicin.
Track This Code in RVU Edge
Log procedures, calculate wRVUs, and benchmark against MGMA data — all in one app.
CPT® is a registered trademark of the American Medical Association. Data sourced from CMS Physician Fee Schedule RVU26A. Descriptions, synonyms, and clinical context are original content by RVU Edge.